SlideShare une entreprise Scribd logo
1  sur  8
Télécharger pour lire hors ligne
5th European Conference on Rare Diseases
                    Krakow, 13-15 May 2010

       Cross-border activities of Centres of Expertise

The Epidermolysis Bullosa (EB) House in Salzburg

                                      Dr. Gabriela Pohla-Gubo
           Department of Dermatology, Paracelsus Medical University Salzburg, Austria
    Academy EB House Austria / Laboratory for Immunology, Allergology & Molecular Diagnostics



         General Hospital Salzburg, Muellner Hauptstrasse 48, 5020 Salzburg, AUSTRIA. Email: g.pohla-gubo@salk.at




                                  Salzburg, Austria




Population: Austria 8,3 Mill.
Epidermolysis bullosa (EB)

  Congenital (inborn), rare (orphan), and at time incurable
skin disease

  EB affects approximately 500 people in Austria, about
30.000 persons in the EU, and ~ 500.000 people worldwide

 The youngest EB patients are often called “butterfly
 children” because of their highly sensitive skin which is as
 fragile as the wings of a butterfly.




             Epidermolysis bullosa (EB)
        Painful blisters on the entire body: both externally
     (skin, eyes, etc.) and internally (e.g. inside the mouth
     or in the gastro-intestinal tract)
       Permanent pain and daily difficult wound treatment
       In addition to skin problems: hair loss, nail and tooth
     decay, deformation of the fingers and toes, as well as
     dietary and digestion problems
Someone who suffers from EB has a most difficult and painful
life that – in some cases – is threatened by aggressive skin
tumours and thereby a shortened life expectancy!
DEBRA Austria
              (NGO/support group, founded 1995)

                   1. Best medical treatments
          Goals:   2. Research on finding a cure for EB
                   3. Education

Fundraising and Public Relation…
♦ Press
♦ Advertising
♦ Websites
♦ Events
♦ Direct Mail
♦ …..




                     EB House Austria
General Hospital Salzburg, Paracelsus Medical Universitiy

                   Initiative from DEBRA Austria




                                                            opened 2005

                     Dept. Dermatology   EB House Austria

♦ Construction: ~1,7 Mill. € (1 Mill refunded from the government)
♦ Operation p/Y: ~600.000 € (refunded from DEBRA to the Hospital)

Open to all people with EB and their families !
3 Units at the EB House Austria
♦ At the EB Outpatient Unit, doctors
  and therapists provide state of the
  art medical advice, treatment, and
  support
♦ At the EB Research Laboratory, a
  research team works on techniques
  with the ultimate goal to find a
  cure by developing a successful
  molecular therapy
♦ At the EB Academy, continuous
  multi-disciplinary education and
  training for laypersons and experts
  is provided




                        EB Outpatient Unit
                                  (Dr. Anja Diem)
 ♦ 2 EB-physicians, 2 EB-nurses
    Multidisciplinary medical care
    Group of experts from all fields of medicine
    ♦ Dermatologists
    ♦ Pediatricians/Pediatric surgeons            Other issues…
    ♦ Dentists/Dental surgeons
    ♦ Ophthalmologists
                                           ♦ Genetic counselling
    ♦ Otorhinolaryngologists
    ♦ Internal Specialists
                                           ♦ Patient training (with the family)
    ♦ Gynecologists
                                           ♦ Clinical (patient-applied) research
    ♦ Physical Medicine & Rehabilitation
    ♦ Psychologists….                      ♦ Legal questions
                                           ♦ Rights of handicapped persons
                                           ♦ Questions of financing patients care
                                           ♦ Kindergarden, school, profession…
Crossborder activities
                                                                                            200




Patients from 15 countries at the EB House
                                                                                                  179
                                                                                            180

                                                                                            160




                                                                      Anzahl EB-Patienten
                                                                                            140

                                                                                            120

                                                                                            100

                                                                                            80
                                                                                                                       55
                                                                                            60

                                                                                            40




     Send all diagnostic/clinical documents, pictures…
                                                                                            20                              8          12
                                                                                                        4    1    5              2           1    2    1    1    1    2     2
                                                                                             0
                                                                                                  AT    BG   BR   CH   DE   HR   HU    IT    MY   PL   SE   TR   UA   VAE   YU
                                                                                                                                      Land




     Contact adress/telephone from local physicians…

♦ Reimbursement (outpatient fee Salzburg: € 176,72)
     European Health Insurance Card (EHIC, formerly E 111) –
   treatment for an illness or injury you NOT had before! Only for travelling !
     EU patients with a known disease (like EB): E 112
     ♦ Available at local health insurance. Obligatory: date of treatment!
     ♦ E 112 not available: selfpay patient! Possibility to present bill
     after return, no guarantee of payback. Risk at the patient!
                    Patients often treated free of charge!
     If necessary (external advice) we help with search for funding (e.g. via DEBRA)

♦ Other experiences: social, language, post-treatment care…




                             EB Laboratory
                             (Prof. Dr. Johann Bauer)

 ♦ 1 EB-physician, 15 EB-scientists

    Diagnostics (Mutations, prenatal/predictive)
    Basic Research (e.g. Cancer)
    Therapy/Gene therapy (Transsplicing)
    ♦ Projects
      ♦ Localized gene therapy for JEB & DEB
      ♦ Cancer therapy for RDEB patients
      ♦ Induction of immunological tolerance
      ♦ Wound healing and scarring in EB
      ♦ Small molecules (pharmaceutical treatment)…
EB Academy
                     (Dr. Gabriela Pohla-Gubo)
♦ 1 EB-specialist, 1 EB-assistent
  Future-oriented education and training
  ♦ Patients and their relatives
  ♦ Doctors, therapists, nurses, social workers…
  ♦ Scientists
  Organization annual advanced training program
  ♦ Seminars, Workshops, Conferences, Congresses…
  Other issues…
   ♦ EB Registry Austria
                                                      200
                                                            179
                                                      180
                                                      160




                                Anzahl EB-Patienten
                                                      140
                                                      120




   ♦ Publications, “Library“
                                                      100
                                                      80
                                                                                            55
                                                      60

                                                      40

                                                      20                                            8                    12
                                                                    4   1         5                               2               1       2      1    1         1      2     2
                                                       0
                                                            AT     BG   BR        CH        DE      HR        HU         IT       MY      PL     SE   TR        UA    VA E   YU




   ♦ Website www.eb-haus.eu
                                                                                                                       Land




   ♦ Journal EB-Haus aktuell
                                                                  300
                                                                             276 (+18)


                                                                  250


                                                                  200                                                                                 Gesamt
                                                                                                                                                      EBS




   ♦ Social networking
                                                                                                                                                      EBJ
                                                                  150
                                                                                                                                                      EBD
                                                                                         109 (+2)                 106 (+9)                            Kindler
                                                                  100                                                                                 unklassifiert

                                                                                                    48 (+6)
                                                                  50
                                                                                                                                       11 (+1)
                                                                                                                              2




   ♦ Service for donors…
                                                                   0
                                                                                                              1




                        EB Academy
                     Networking - Visiting specialists
                                                                                                                                                                                  Dédeé Murrell (AU)
                                                                                                                                                                                  Kieran Moran (AU)
                                                                                                                                                                                  Michele De Luca (IT)
                                                                                                                                                                                  Giovanna Zambruno (IT)
                                                                                                                                                                                  Maja Elachem (IT)
                                                                                                                                                                                  Paola Zotti (IT)
                                                                                                                                                                                  Jo-David Fine (US)
                                                                                                                                                                                  Lloyd Mitchell (US)
                                                                                                                                                                                  Mary Sprague (US)
                                                                                                                                                                                  John McGrath (UK)
                                                                                                                                                                                  Clare Robinson (UK)
                                                                                                                                                                                  Robin Eady (UK)
                                                                                                                                                                                  Jemma Mellerio (UK)
                                                                                                                                                                                  Slobodna Murat –Susic (HR)
                                                                                                                                                                                  Julio Salas (MX)
                                                                                                                                                                                  Rodrigo Cepeda (MX)
                                                                                                                                                                                  Francis Pallison (CL)
                                                                                                                                                                                  Fernando Rodriguez (CL)
                                                                                                                                                                                  Vania Declair Cohen (BR)
                                                                                                                                                                                  Pakeeza Shaiq (PK)
                                                                                                                                                                                  …….
EB House Austria - Next Steps…
♦ Intensification of Cross-border Healthcare
♦ Intensification of Research
♦ Translation of Research into Treatment

  EB Registry
♦ PROGRAMME OF COMMUNITY ACTION IN THE FIELD OF HEALTH
(2008-2013). DG SANCO
♦ Proposal submitted 19 March 2010
European Genetic Registry of Inherited Epidermolysis Bullosa (EB)

 ♦ 3 year project
 ♦ Target: 1,500 patients
 ♦ Data resources open and accessible




                        EB Registry
♦ Centres and associated partners:
     1) Leena Bruckner-Tuderman, Freiburg, Germany
     2) Giovanna Zambruno, Rome, Italy
     3) John McGrath, London, UK
     4) Johann Bauer, Gabriela Pohla-Gubo, Salzburg, Austria
     5) Jean-Philippe Lacour (Meneguzzi), Nice, France
     6) Alain Hovnanian, Paris, France
     7) Marcel Jonkman, Groningen, The Netherlands
     8) Sarolta Karpati, Budapest, Hungary
     9) Anders Vahlquist, Uppsala, Sweden
     10) Marcela Del Rio, Madrid, Spain
     11) IT Partner (Freiburg, Germany)
     12) DEBRA International

  Key instrument to increase knowledge on EB
        and develop clinical research !!!
EB House Austria – Our wishes..
(1) Approval as European Centre of Reference (ECR)
      According to the final report on ECR from RDTF expert group (2005):
                           All criteria are fulfilled !!!
1.   Appropriate capacities to diagnose, to do follow-up and manage
     patients with evidence of good outcomes when applicable
2.   Attractiveness measured through the volume of activity which
     needs to be significantly larger than anticipated from the
     prevalence of the diseases and the catchment area…
3.   Capacity to provide expert advice on diagnosis and care
4.   Capacity to produce and adhere to good practice guidelines and to
     implement outcome measures and quality control
5.   Demonstration of a multi-disciplinary approach
6.   High level of expertise and experience documented through
     publications, grants or honorific positions, teaching and training
     activities
7.   Strong contribution to research
8.   Close links and collaboration with other expert centres at national
     and international level and capacity to network
9.   Close links and collaboration with patients associations where they
     exist




              EB House Austria – Our wishes..
      (2) Answering many open questions
♦ … what kind of therapy is the most successful?
♦ … what kind of prevention is necessary and useful?
♦ ….how can we improve the quality of life of our patients!
♦ … ?????

      (3) Finding additional partners
♦ … ready for social engagement!
♦ … ready for continuing support of our projects!
♦ … ready to maintain the work at the EB House Austria!


                                                              Thank you for
                                                              the attention !

Contenu connexe

En vedette (8)

Session 25 andrzej_rys
Session 25 andrzej_rysSession 25 andrzej_rys
Session 25 andrzej_rys
 
Workshop 3 - "Presentation of the Epi-Rare project"
Workshop 3 - "Presentation of the Epi-Rare project"Workshop 3 - "Presentation of the Epi-Rare project"
Workshop 3 - "Presentation of the Epi-Rare project"
 
Session 25 steffen_suchert
Session 25 steffen_suchertSession 25 steffen_suchert
Session 25 steffen_suchert
 
Session 21 marjet stamsnijder 1
Session 21 marjet stamsnijder 1Session 21 marjet stamsnijder 1
Session 21 marjet stamsnijder 1
 
Rare disease day 2011 highlights
Rare disease day 2011 highlightsRare disease day 2011 highlights
Rare disease day 2011 highlights
 
Session 3 fons_gabreels
Session 3 fons_gabreelsSession 3 fons_gabreels
Session 3 fons_gabreels
 
RareConnect.org Update 2016
RareConnect.org Update 2016RareConnect.org Update 2016
RareConnect.org Update 2016
 
Session 2 graf_von_der_schulenburg
Session 2 graf_von_der_schulenburgSession 2 graf_von_der_schulenburg
Session 2 graf_von_der_schulenburg
 

Plus de EURORDIS - Rare Diseases Europe

RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...EURORDIS - Rare Diseases Europe
 
RareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare diseaseRareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare diseaseEURORDIS - Rare Diseases Europe
 
Update on the Mysasthenia Gravis community on RareConnect.org
Update on the Mysasthenia Gravis community on RareConnect.orgUpdate on the Mysasthenia Gravis community on RareConnect.org
Update on the Mysasthenia Gravis community on RareConnect.orgEURORDIS - Rare Diseases Europe
 
RareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients GloballyRareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients GloballyEURORDIS - Rare Diseases Europe
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...EURORDIS - Rare Diseases Europe
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...EURORDIS - Rare Diseases Europe
 
Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...EURORDIS - Rare Diseases Europe
 
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe" Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe" EURORDIS - Rare Diseases Europe
 
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"EURORDIS - Rare Diseases Europe
 
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"EURORDIS - Rare Diseases Europe
 
Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...EURORDIS - Rare Diseases Europe
 
Workshop 3 - "Presentation of the concept, definitions and terminology"
Workshop 3 - "Presentation of the concept, definitions and terminology"Workshop 3 - "Presentation of the concept, definitions and terminology"
Workshop 3 - "Presentation of the concept, definitions and terminology"EURORDIS - Rare Diseases Europe
 
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"Workshop 4 - "Feedback from the 15 National Conferences on Research policy"
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"EURORDIS - Rare Diseases Europe
 
Conference 4 - The patient experience in the development and implementation ...
Conference 4 - The patient experience  in the development and implementation ...Conference 4 - The patient experience  in the development and implementation ...
Conference 4 - The patient experience in the development and implementation ...EURORDIS - Rare Diseases Europe
 
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...EURORDIS - Rare Diseases Europe
 
Workshop 2 - "Presentation of the concept, definitions and terminology"
Workshop 2  - "Presentation of the concept, definitions and terminology" Workshop 2  - "Presentation of the concept, definitions and terminology"
Workshop 2 - "Presentation of the concept, definitions and terminology" EURORDIS - Rare Diseases Europe
 

Plus de EURORDIS - Rare Diseases Europe (20)

RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...RareConnect.org webinar How to use Twitter to build your online rare disease ...
RareConnect.org webinar How to use Twitter to build your online rare disease ...
 
RareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare diseaseRareConnect.org webinar: How to start an awareness day for your rare disease
RareConnect.org webinar: How to start an awareness day for your rare disease
 
The Value of Online Communities
The Value of Online CommunitiesThe Value of Online Communities
The Value of Online Communities
 
Updates to RareConnect.org in 2014
Updates to RareConnect.org in 2014Updates to RareConnect.org in 2014
Updates to RareConnect.org in 2014
 
Update on the Mysasthenia Gravis community on RareConnect.org
Update on the Mysasthenia Gravis community on RareConnect.orgUpdate on the Mysasthenia Gravis community on RareConnect.org
Update on the Mysasthenia Gravis community on RareConnect.org
 
Surveys and polls: The RareConnect.org Experience
Surveys and polls: The RareConnect.org ExperienceSurveys and polls: The RareConnect.org Experience
Surveys and polls: The RareConnect.org Experience
 
RareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients GloballyRareConnect.org - Connecting Rare Disease Patients Globally
RareConnect.org - Connecting Rare Disease Patients Globally
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...
 
Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...Results of Survey on the role of Patient Groups in Research and their priorit...
Results of Survey on the role of Patient Groups in Research and their priorit...
 
Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...Results of a survey on the role of Patient Groups in Research and their prio...
Results of a survey on the role of Patient Groups in Research and their prio...
 
Conference 3 "Outcomes of 15 National Conferences, "
Conference 3   "Outcomes of 15 National Conferences, "Conference 3   "Outcomes of 15 National Conferences, "
Conference 3 "Outcomes of 15 National Conferences, "
 
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe" Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
Workshop 1 - "The EU tender on Newborn Screening for rare disordersin Europe"
 
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
Workshop 7 - "EUROCAT Study on Prevention of Congenital Anomalies"
 
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
Workshop 3 - "Outcome of the RD Task Force and EPPOSI Workshop"
 
Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...Conference 5 - “Patient’s Experience in the Development and Implementation of...
Conference 5 - “Patient’s Experience in the Development and Implementation of...
 
Workshop 3 - "Presentation of the concept, definitions and terminology"
Workshop 3 - "Presentation of the concept, definitions and terminology"Workshop 3 - "Presentation of the concept, definitions and terminology"
Workshop 3 - "Presentation of the concept, definitions and terminology"
 
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"Workshop 4 - "Feedback from the 15 National Conferences on Research policy"
Workshop 4 - "Feedback from the 15 National Conferences on Research policy"
 
Conference 4 - The patient experience in the development and implementation ...
Conference 4 - The patient experience  in the development and implementation ...Conference 4 - The patient experience  in the development and implementation ...
Conference 4 - The patient experience in the development and implementation ...
 
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...
Workshop 2 - "EURORDIS Policy recommendations based on EURORDIS Declaration, ...
 
Workshop 2 - "Presentation of the concept, definitions and terminology"
Workshop 2  - "Presentation of the concept, definitions and terminology" Workshop 2  - "Presentation of the concept, definitions and terminology"
Workshop 2 - "Presentation of the concept, definitions and terminology"
 

Dernier

CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
QUESTIONS & ANSWERS FOR QUALITY ASSURANCE, RADIATIONBIOLOGY& RADIATION HAZARD...
QUESTIONS & ANSWERS FOR QUALITY ASSURANCE, RADIATIONBIOLOGY& RADIATION HAZARD...QUESTIONS & ANSWERS FOR QUALITY ASSURANCE, RADIATIONBIOLOGY& RADIATION HAZARD...
QUESTIONS & ANSWERS FOR QUALITY ASSURANCE, RADIATIONBIOLOGY& RADIATION HAZARD...Ganesan Yogananthem
 
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...bkling
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Peter Embi
 
concept of total quality management (TQM).
concept of total quality management (TQM).concept of total quality management (TQM).
concept of total quality management (TQM).kishan singh tomar
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsMedicoseAcademics
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)Mohamed Rizk Khodair
 
World-TB-Day-2023_Presentation_English.pptx
World-TB-Day-2023_Presentation_English.pptxWorld-TB-Day-2023_Presentation_English.pptx
World-TB-Day-2023_Presentation_English.pptxsumanchaulagain3
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfDolisha Warbi
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets barmohitRahangdale
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 

Dernier (20)

CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
QUESTIONS & ANSWERS FOR QUALITY ASSURANCE, RADIATIONBIOLOGY& RADIATION HAZARD...
QUESTIONS & ANSWERS FOR QUALITY ASSURANCE, RADIATIONBIOLOGY& RADIATION HAZARD...QUESTIONS & ANSWERS FOR QUALITY ASSURANCE, RADIATIONBIOLOGY& RADIATION HAZARD...
QUESTIONS & ANSWERS FOR QUALITY ASSURANCE, RADIATIONBIOLOGY& RADIATION HAZARD...
 
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024
 
concept of total quality management (TQM).
concept of total quality management (TQM).concept of total quality management (TQM).
concept of total quality management (TQM).
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functions
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)
 
World-TB-Day-2023_Presentation_English.pptx
World-TB-Day-2023_Presentation_English.pptxWorld-TB-Day-2023_Presentation_English.pptx
World-TB-Day-2023_Presentation_English.pptx
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
Cone beam CT: concepts and applications.pptx
Cone beam CT: concepts and applications.pptxCone beam CT: concepts and applications.pptx
Cone beam CT: concepts and applications.pptx
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets bar
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 

Session 17 pohla_gubo

  • 1. 5th European Conference on Rare Diseases Krakow, 13-15 May 2010 Cross-border activities of Centres of Expertise The Epidermolysis Bullosa (EB) House in Salzburg Dr. Gabriela Pohla-Gubo Department of Dermatology, Paracelsus Medical University Salzburg, Austria Academy EB House Austria / Laboratory for Immunology, Allergology & Molecular Diagnostics General Hospital Salzburg, Muellner Hauptstrasse 48, 5020 Salzburg, AUSTRIA. Email: g.pohla-gubo@salk.at Salzburg, Austria Population: Austria 8,3 Mill.
  • 2. Epidermolysis bullosa (EB) Congenital (inborn), rare (orphan), and at time incurable skin disease EB affects approximately 500 people in Austria, about 30.000 persons in the EU, and ~ 500.000 people worldwide The youngest EB patients are often called “butterfly children” because of their highly sensitive skin which is as fragile as the wings of a butterfly. Epidermolysis bullosa (EB) Painful blisters on the entire body: both externally (skin, eyes, etc.) and internally (e.g. inside the mouth or in the gastro-intestinal tract) Permanent pain and daily difficult wound treatment In addition to skin problems: hair loss, nail and tooth decay, deformation of the fingers and toes, as well as dietary and digestion problems Someone who suffers from EB has a most difficult and painful life that – in some cases – is threatened by aggressive skin tumours and thereby a shortened life expectancy!
  • 3. DEBRA Austria (NGO/support group, founded 1995) 1. Best medical treatments Goals: 2. Research on finding a cure for EB 3. Education Fundraising and Public Relation… ♦ Press ♦ Advertising ♦ Websites ♦ Events ♦ Direct Mail ♦ ….. EB House Austria General Hospital Salzburg, Paracelsus Medical Universitiy Initiative from DEBRA Austria opened 2005 Dept. Dermatology EB House Austria ♦ Construction: ~1,7 Mill. € (1 Mill refunded from the government) ♦ Operation p/Y: ~600.000 € (refunded from DEBRA to the Hospital) Open to all people with EB and their families !
  • 4. 3 Units at the EB House Austria ♦ At the EB Outpatient Unit, doctors and therapists provide state of the art medical advice, treatment, and support ♦ At the EB Research Laboratory, a research team works on techniques with the ultimate goal to find a cure by developing a successful molecular therapy ♦ At the EB Academy, continuous multi-disciplinary education and training for laypersons and experts is provided EB Outpatient Unit (Dr. Anja Diem) ♦ 2 EB-physicians, 2 EB-nurses Multidisciplinary medical care Group of experts from all fields of medicine ♦ Dermatologists ♦ Pediatricians/Pediatric surgeons Other issues… ♦ Dentists/Dental surgeons ♦ Ophthalmologists ♦ Genetic counselling ♦ Otorhinolaryngologists ♦ Internal Specialists ♦ Patient training (with the family) ♦ Gynecologists ♦ Clinical (patient-applied) research ♦ Physical Medicine & Rehabilitation ♦ Psychologists…. ♦ Legal questions ♦ Rights of handicapped persons ♦ Questions of financing patients care ♦ Kindergarden, school, profession…
  • 5. Crossborder activities 200 Patients from 15 countries at the EB House 179 180 160 Anzahl EB-Patienten 140 120 100 80 55 60 40 Send all diagnostic/clinical documents, pictures… 20 8 12 4 1 5 2 1 2 1 1 1 2 2 0 AT BG BR CH DE HR HU IT MY PL SE TR UA VAE YU Land Contact adress/telephone from local physicians… ♦ Reimbursement (outpatient fee Salzburg: € 176,72) European Health Insurance Card (EHIC, formerly E 111) – treatment for an illness or injury you NOT had before! Only for travelling ! EU patients with a known disease (like EB): E 112 ♦ Available at local health insurance. Obligatory: date of treatment! ♦ E 112 not available: selfpay patient! Possibility to present bill after return, no guarantee of payback. Risk at the patient! Patients often treated free of charge! If necessary (external advice) we help with search for funding (e.g. via DEBRA) ♦ Other experiences: social, language, post-treatment care… EB Laboratory (Prof. Dr. Johann Bauer) ♦ 1 EB-physician, 15 EB-scientists Diagnostics (Mutations, prenatal/predictive) Basic Research (e.g. Cancer) Therapy/Gene therapy (Transsplicing) ♦ Projects ♦ Localized gene therapy for JEB & DEB ♦ Cancer therapy for RDEB patients ♦ Induction of immunological tolerance ♦ Wound healing and scarring in EB ♦ Small molecules (pharmaceutical treatment)…
  • 6. EB Academy (Dr. Gabriela Pohla-Gubo) ♦ 1 EB-specialist, 1 EB-assistent Future-oriented education and training ♦ Patients and their relatives ♦ Doctors, therapists, nurses, social workers… ♦ Scientists Organization annual advanced training program ♦ Seminars, Workshops, Conferences, Congresses… Other issues… ♦ EB Registry Austria 200 179 180 160 Anzahl EB-Patienten 140 120 ♦ Publications, “Library“ 100 80 55 60 40 20 8 12 4 1 5 2 1 2 1 1 1 2 2 0 AT BG BR CH DE HR HU IT MY PL SE TR UA VA E YU ♦ Website www.eb-haus.eu Land ♦ Journal EB-Haus aktuell 300 276 (+18) 250 200 Gesamt EBS ♦ Social networking EBJ 150 EBD 109 (+2) 106 (+9) Kindler 100 unklassifiert 48 (+6) 50 11 (+1) 2 ♦ Service for donors… 0 1 EB Academy Networking - Visiting specialists Dédeé Murrell (AU) Kieran Moran (AU) Michele De Luca (IT) Giovanna Zambruno (IT) Maja Elachem (IT) Paola Zotti (IT) Jo-David Fine (US) Lloyd Mitchell (US) Mary Sprague (US) John McGrath (UK) Clare Robinson (UK) Robin Eady (UK) Jemma Mellerio (UK) Slobodna Murat –Susic (HR) Julio Salas (MX) Rodrigo Cepeda (MX) Francis Pallison (CL) Fernando Rodriguez (CL) Vania Declair Cohen (BR) Pakeeza Shaiq (PK) …….
  • 7. EB House Austria - Next Steps… ♦ Intensification of Cross-border Healthcare ♦ Intensification of Research ♦ Translation of Research into Treatment EB Registry ♦ PROGRAMME OF COMMUNITY ACTION IN THE FIELD OF HEALTH (2008-2013). DG SANCO ♦ Proposal submitted 19 March 2010 European Genetic Registry of Inherited Epidermolysis Bullosa (EB) ♦ 3 year project ♦ Target: 1,500 patients ♦ Data resources open and accessible EB Registry ♦ Centres and associated partners: 1) Leena Bruckner-Tuderman, Freiburg, Germany 2) Giovanna Zambruno, Rome, Italy 3) John McGrath, London, UK 4) Johann Bauer, Gabriela Pohla-Gubo, Salzburg, Austria 5) Jean-Philippe Lacour (Meneguzzi), Nice, France 6) Alain Hovnanian, Paris, France 7) Marcel Jonkman, Groningen, The Netherlands 8) Sarolta Karpati, Budapest, Hungary 9) Anders Vahlquist, Uppsala, Sweden 10) Marcela Del Rio, Madrid, Spain 11) IT Partner (Freiburg, Germany) 12) DEBRA International Key instrument to increase knowledge on EB and develop clinical research !!!
  • 8. EB House Austria – Our wishes.. (1) Approval as European Centre of Reference (ECR) According to the final report on ECR from RDTF expert group (2005): All criteria are fulfilled !!! 1. Appropriate capacities to diagnose, to do follow-up and manage patients with evidence of good outcomes when applicable 2. Attractiveness measured through the volume of activity which needs to be significantly larger than anticipated from the prevalence of the diseases and the catchment area… 3. Capacity to provide expert advice on diagnosis and care 4. Capacity to produce and adhere to good practice guidelines and to implement outcome measures and quality control 5. Demonstration of a multi-disciplinary approach 6. High level of expertise and experience documented through publications, grants or honorific positions, teaching and training activities 7. Strong contribution to research 8. Close links and collaboration with other expert centres at national and international level and capacity to network 9. Close links and collaboration with patients associations where they exist EB House Austria – Our wishes.. (2) Answering many open questions ♦ … what kind of therapy is the most successful? ♦ … what kind of prevention is necessary and useful? ♦ ….how can we improve the quality of life of our patients! ♦ … ????? (3) Finding additional partners ♦ … ready for social engagement! ♦ … ready for continuing support of our projects! ♦ … ready to maintain the work at the EB House Austria! Thank you for the attention !